FDA-Inspected Site

M & L Pharmaceutical, Inc.

3 FDA inspections are on record for M & L Pharmaceutical, Inc. in San Bernardino, United States.

Clean· No action indicated

San Bernardino, United States · Last updated July 10, 2026

Overview

  • 3 FDA inspections are on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2026-04-28.

At a glance

Inspections

3

Form 483s

1

EIRs

0

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
22 Apr 2026 – 28 Apr 2026Foods & CosmeticsClean
10 Feb 2020 – 12 Feb 2020Foods & Cosmetics483View 483 →
23 Aug 2017Foods & CosmeticsClean

Observations on record

Form 483 observations cited at this site, most recent first.

12 Feb 2020
21 CFR 111.70(e)

Specifications - identity, purity, strength, composition

Cited by Natalie J Reese

12 Feb 2020
21 CFR 111.75(a)(2)

Appropriate tests, examinations; certificate of analysis

Cited by Natalie J Reese

12 Feb 2020
21 CFR 111.75(b)(1)

Specifications met, in-process - quality finished batch

Cited by Natalie J Reese

12 Feb 2020
21 CFR 111.75(h)(2)

Tests, examinations - scientifically valid

Cited by Natalie J Reese

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 111.70(e)Cited across public-safe Form 483 observations1x
21 CFR 111.75(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 111.75(b)(1)Cited across public-safe Form 483 observations1x
21 CFR 111.75(h)(2)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind M & L Pharmaceutical, Inc.'s 1 Form 483

Recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat